Skip to content
DefDex

Federal award

BIOFIRE DIAGNOSTICS LLC

W81K0221P0018

Contract

Obligated and Ceiling

Obligated (net)
$1,910,278.05
Ceiling (potential value, not spending)
$1,910,278.05
Current value
$1,910,278.05
Gross positive obligations
$2,347,019.00

Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.

Award Details

Recipient
BIOFIRE DIAGNOSTICS LLC · TBBNREFT3LD3
Owner company
Not a reviewed companyNo reviewed company owns this recipient.
Reported parent
COMPAGNIE MERIEUX ALLIANCE · WG3DJHG5C1C7
Awarding agency
Department of War · sub-agency 2100 · office W81K02
Funding agency
Department of War · sub-agency 97DH
Product or service (PSC)
6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS
Industry (NAICS)
334516 · ANALYTICAL LABORATORY INSTRUMENT MANUFACTURING
PIID
W81K0221P0018
Award type code
B
Actions
15 · Nov 18, 2020 to Jun 27, 2025
Why it is listed
gross positive obligations of $100k or more (contracts)

Open this award on USAspending →

Action History15

Award actions
DateFYModAction typeObligationCompany in company totals
Jun 27, 2025FY2025P00014B−$489.10
—
Apr 4, 2025FY2025P00013B−$367,551.95
—
Dec 26, 2024FY2025P00012B−$68,699.90
—
Oct 31, 2024FY2025P00011C$577,214.20
—
Aug 9, 2024FY2024P00010G$0.00
—
May 7, 2024FY2024P00009B$179,684.00
—
Oct 25, 2023FY2024P00008C$397,530.20
—
Jul 18, 2023FY2023P00007G$0.00
—
Nov 8, 2022FY2023P00006C$397,530.20
—
Jul 8, 2022FY2022P00005G$0.00
—
Mar 11, 2022FY2022P00004B$0.00
—
Nov 1, 2021FY2022P00003C$397,530.20
—
May 27, 2021FY2021P00002G$0.00
—
May 20, 2021FY2021P00001B$0.00
—
Nov 18, 2020FY20210—$397,530.20
—

Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.